4.7 Article

Novel Antitumor Cisplatin and Transplatin Derivatives Containing 1-Methyl-7-Azaindole: Synthesis, Characterization, and Cellular Responses

期刊

JOURNAL OF MEDICINAL CHEMISTRY
卷 58, 期 2, 页码 847-859

出版社

AMER CHEMICAL SOC
DOI: 10.1021/jm501420k

关键词

-

资金

  1. National Program of Sustainability I [LO1204]
  2. Operational Program Education for Competitiveness-European Social Fund of the Ministry of Education, Youth and Sports of the Czech Republic [CZ 1.07/2.3.00/20.0057]
  3. University of Bari Aldo Moro
  4. Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB)
  5. Italian Ministero dell'Universita e della Ricerca [PON 01078, FIRB RINAME RBAP114AMK]
  6. Palacky University in Olomouc [IGAPrF2014029]
  7. Ministry of Education, Youth and Sports of the Czech Republic [LD14019]

向作者/读者索取更多资源

The current work investigates the effect of new bifunctional and mononuclear Pt(II) compounds, the cis- and trans-isomers of [PtCl2(NH3)(L)] (L = 1-methyl-7-azaindole, compounds 1 and 2, respectively), on growth and viability of human carcinoma cells as well as their putative mechanism(s) of cytotoxicity. The results show that substitution of 1-methyl-7-azaindole for ammine in cisplatin or transplatin results in an increase of the toxic efficiency, selectivity for tumor cells in cisplatin-resistant cancer cells, and activation of the trans geometry. The differences in the cytotoxic activities of 1 and 2 were suggested to be due to their different DNA binding mode, different capability to induce cell cycle perturbations, and fundamentally different role of transcription factor p53 in their mechanism of action. Interestingly, both isomers make it possible to detect their cellular uptake and distribution in living cells by confocal microscopy without their modification with an optically active tag.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Multidisciplinary

19F NMR Allows the Investigation of the Fate of Platinum(IV) Prodrugs in Physiological Conditions

Siming Yuan, Yang Zhu, Yi Dai, Yu Wang, Duo Jin, Manman Liu, Liqin Tang, Fabio Arnesano, Giovanni Natile, Yangzhong Liu

Summary: Pt-IV prodrugs can overcome resistance and side effects of conventional Pt-II anticancer therapies by efficiently promoting the two electrons reduction of Pt-IV to Pt-II. The activation of Pt-FBA is highly dependent upon the type of cancer cells, and FBA can shuttle out of the cell after Pt-FBA is reduced intracellularly. The F-19 NMR approach has the advantage of avoiding the interference of all background signals when investigating the activation of Pt-IV prodrugs.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2022)

Article Chemistry, Inorganic & Nuclear

Synthesis and characterization of new platinum(II) complexes with cyclic iminoether-type ligands having the azomethine group out of cycle

Nicola Margiotta, Concetta Pacifico, Teresa Saltarella, Giovanni Natile, Francesco P. Intini

Summary: The synthesis and characterization of platinum complexes with the 2-iminotetrahydrofuran ligand, where the iminic nitrogen is outside the cycle and can keep its proton, are described in this paper. Apart from isolating the pure E and Z isomers, diiodido derivative and cis isomer were also prepared.

INORGANICA CHIMICA ACTA (2022)

Article Biochemistry & Molecular Biology

Metallohelix vectors for efficient gene delivery via cationic DNA nanoparticles

Jaroslav Malina, Hana Kostrhunova, Vojtech Novohradsky, Peter Scott, Viktor Brabec

Summary: The design of efficient and safe gene delivery vehicles remains a major challenge for gene therapy. Metal complexes with high affinity for nucleic acids are emerging as an attractive option for gene delivery systems. Certain metallohelices have been discovered to act as nonviral DNA delivery vectors capable of mediating efficient gene transfection, forming globular DNA particles that protect the DNA from degradation, and successfully being processed by cells.

NUCLEIC ACIDS RESEARCH (2022)

Article Biochemistry & Molecular Biology

Gallium(III) Complex with Cloxyquin Ligands Induces Ferroptosis in Cancer Cells and Is a Potent Agent against Both Differentiated and Tumorigenic Cancer Stem Rhabdomyosarcoma Cells

Monika Hreusova, Vojtech Novohradsky, Lenka Markova, Hana Kostrhunova, Ivan Potocnak, Viktor Brabec, Jana Kasparkova

Summary: In this study, a gallium(III) complex with cloxyquin ligands is found to effectively inhibit the proliferation of rhabdomyosarcoma cells, a type of aggressive and difficult-to-treat cancer in children. The complex exhibits selective toxicity towards cancer cells compared to noncancerous fibroblasts. It induces ferroptosis in rhabdomyosarcoma cells through interference with iron metabolism, and is capable of killing both bulk and stem cells. This is the first non-iron metal compound shown to induce ferroptosis in cancer cells.

BIOINORGANIC CHEMISTRY AND APPLICATIONS (2022)

Article Biochemistry & Molecular Biology

Improvement of Kiteplatin Efficacy by a Benzoato Pt(IV) Prodrug Suitable for Oral Administration

Alessandra Barbanente, Valentina Gandin, Cecilia Ceresa, Cristina Marzano, Nicoletta Ditaranto, James D. Hoeschele, Giovanni Natile, Fabio Arnesano, Concetta Pacifico, Francesco P. Intini, Nicola Margiotta

Summary: The Pt(IV) prodrug of kiteplatin, cis,trans,cis-[PtCl2(OBz)(2)(cis-1,4-DACH)], has shown promising anticancer activity at nanomolar concentrations, good stability in acidic conditions for oral administration, and comparable tumor reduction effectiveness to cisplatin in in vivo studies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Chemistry, Inorganic & Nuclear

Cyclometalated Benzimidazole Osmium(II) Complexes with Antiproliferative Activity in Cancer Cells Disrupt Calcium Homeostasis

Alba Hernandez-Garcia, Lenka Markova, Maria Dolores Santana, Jitka Pracharova, Delia Bautista, Hana Kostrhunova, Vojtech Novohradsky, Viktor Brabec, Jose Ruiz, Jana Kasparkova

Summary: This study presents the synthesis and characterization of six new heteroleptic osmium(II) complexes with varying substituents in the R3 position of the phenyl ring of the cyclometalating C^N ligand. These complexes are highly kinetically inert and absorb a full-wavelength range of visible light. The antiproliferative activity of these complexes has been investigated using human cancer and noncancerous cell cultures, showing that they are more potent than conventional cisplatin. The mechanism of action involves the activation of the endoplasmic reticulum stress pathway and disruption of calcium homeostasis.

INORGANIC CHEMISTRY (2023)

Article Chemistry, Medicinal

Platinum(IV) Derivatives of [Pt(1S,2S-diaminocyclohexane)(5,6-dimethyl-1,10-phenanthroline)] with Diclofenac Ligands in the Axial Positions: A New Class of Potent Multi-action Agents Exhibiting Selectivity to Cancer Cells

Hana Kostrhunova, Brondwyn S. McGhie, Lenka Markova, Olga Novakova, Jana Kasparkova, Janice R. Aldrich-Wright, Viktor Brabec

Summary: The platinum(II) complex Pt(II)56MeSS exhibits high potency against cancer cells but also displays side toxicity and in vivo activity. The synthesis of new platinum(IV) prodrugs combining Pt(II)56MeSS with diclofenac (DCF) is described. These Pt(IV) complexes show similar mechanisms of action as Pt(II)56MeSS and DCF, promoting antiproliferative activity and inducing cell death and immunogenic cell death in cancer cells.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Biochemistry & Molecular Biology

Metallohelices stabilize DNA three-way junctions and induce DNA damage in cancer cells

Jaroslav Malina, Hana Kostrhunova, Peter Scott, Viktor Brabec

Summary: Fe(II)-based metallohelices were found to stabilize various DNA junctions, with the highest selectivity for the Y-shaped 3WJ. These metallohelices were shown to efficiently kill cancer cells and induce DNA damage, offering potential therapeutic benefits.

NUCLEIC ACIDS RESEARCH (2023)

Article Chemistry, Multidisciplinary

Multitargeting Prodrugs that Release Oxaliplatin, Doxorubicin and Gemcitabine are Potent Inhibitors of Tumor Growth and Effective Inducers of Immunogenic Cell Death

Amrita Sarkar, Vojtech Novohradsky, Moumita Maji, Tomer Babu, Lenka Markova, Hana Kostrhunova, Jana Kasparkova, Valentina Gandin, Viktor Brabec, Dan Gibson

Summary: A multitargeting prodrug (2) that releases gemcitabine, oxaliplatin, and doxorubicin in their active form in cancer cells is a potent cytotoxic agent. It selectively targets cancer cells with high selectivity indices and induces the release of DAMPs in CT26 cells. The prodrug also inhibits tumor growth in murine models with lower body weight loss compared to FDA drugs.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2023)

Article Chemistry, Medicinal

Ir(III) Compounds Containing a Terdentate Ligand Are Potent Inhibitors of Proliferation and Effective Antimetastatic Agents in Aggressive Triple-Negative Breast Cancer Cells

Vojtech Novohradsky, Alicia Marco, Lenka Markova, Natalia Cutillas, Jose Ruiz, Viktor Brabec

Summary: In this study, a series of new octahedral iridium(III) complexes Ir1-Ir9 were reported, which showed potential for inhibiting metastasis in triple-negative breast cancer. The results demonstrated that the structural modifications within the complexes strongly influenced their anti-metastatic properties, with complex Ir1 exhibiting the highest activity. Contrary to the effects of the conventional chemotherapy drug doxorubicin, which promoted metastatic properties of TNBC cells, the results suggested that doxorubicin therapy may increase the risk of breast cancer metastasis.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Chemistry, Inorganic & Nuclear

Triplex metallohelices have enantiomer-dependent mechanisms of action in colon cancer cells

J. P. C. Coverdale, H. Kostrhunova, L. Markova, H. Song, M. Postings, H. E. Bridgewater, V. Brabec, N. J. Rogers, P. Scott

Summary: Self-assembled enantiomers of a di-iron metallohelix showed different antiproliferative activities against HCT116 colon cancer cells, with the ?-helicity compound being more potent than the Delta compound. The accumulation and localization studies suggest that the ? enantiomer undergoes carrier-mediated efflux, while the Delta enantiomer undergoes equilibrative process. The binding of the ? metallohelix to DNA and inhibition of tubulin and actin networks contribute to its G(2)/M arrest effect on cells.

DALTON TRANSACTIONS (2023)

Article Biochemistry & Molecular Biology

The mechanism of antiproliferative activity of the oxaliplatin pyrophosphate derivative involves its binding to nuclear DNA in cancer cells

Jitka Pracharova, Hana Kostrhunova, Alessandra Barbanente, Nicola Margiotta, Viktor Brabec

Summary: This study confirms the excellent antiproliferative activity of the phosphaplatin derivative RRD2 in various cancer cell lines and analyzes its binding to nuclear DNA. The results demonstrate that DNA lesions caused by RRD2 contribute to killing cancer cells. Additionally, RRD2 accumulates in cancer cells to a lesser extent than cisplatin but exhibits similar binding efficiency to nuclear DNA after accumulation.

JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2023)

Article Chemistry, Inorganic & Nuclear

Dinuclear nickel(ii) supramolecular helicates down-regulate gene expression in human cells by stabilizing DNA G-quadruplexes formed in the promoter regions

Jaroslav Malina, Hana Kostrhunova, Viktor Brabec

Summary: In this study, we investigated the interaction between a dinuclear nickel(II) tetracationic supramolecular helicate and DNA G-quadruplexes, and their impact on gene expression. The results showed that the supramolecular helicate preferentially binds to G-quadruplex structures and stabilizes them, leading to the inhibition of DNA synthesis and downregulation of gene expression.

INORGANIC CHEMISTRY FRONTIERS (2022)

Article Biochemistry & Molecular Biology

Is antitumor Pt(IV) complex containing two axial lonidamine ligands a true dual- or multi-action prodrug?

Jana Kasparkova, Hana Kostrhunova, Vojtech Novohradsky, Lili Ma, Guangyu Zhu, Elena R. Milaeva, Alexender A. Shtill, Robin Vinck, Gilles Gasser, Viktor Brabec, Alexey A. Nazarov

Summary: This study investigated the mechanism of action of a Pt(IV) complex 2 with two axial lonidamine ligands, which selectively inhibit aerobic glycolysis. Compared to the parent Pt(II) complex, the presence of two lonidamine ligands increased the antiproliferative activity of complex 2, influenced its cell cycle profile and mechanism of cell death. In 3D cell culture, complex 2 exhibited exceptional antiproliferative activity.

METALLOMICS (2022)

Article Chemistry, Inorganic & Nuclear

Pt(II) complex containing the 1R,2R enantiomer of trans-1,2-diamino-4-cyclohexene ligand effectively and selectively inhibits the viability of aggressive pancreatic adenocarcinoma cells and alters their lipid metabolism

Vojtech Novohradsky, Lenka Markova, Hana Kostrhunova, Marie Svitelova, Jana Kasparkova, Alessandra Barbanente, Paride Papadia, Nicola Margiotta, James D. Hoeschele, Viktor Brabec

Summary: New platinum-based compounds exhibit high potency and selectivity in pancreatic cancer cells, and inhibit lipid synthesis through a novel mechanism, providing a potential theoretical basis for the development of new anticancer drugs.

INORGANIC CHEMISTRY FRONTIERS (2022)

暂无数据